Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1606499

Heterogeneity and distribution characteristics of tertiary lymphoid structures predict prognostic outcome in esophageal squamous cell carcinoma

Provisionally accepted
Chengjuan  ZhangChengjuan Zhang1*Ruihua  BaiRuihua Bai2Yanping  HuYanping Hu3Tao  WangTao Wang4Bin  MaBin Ma5Junxia  ZhangJunxia Zhang6Jing  YuanJing Yuan1Xiance  TangXiance Tang6He  ZhangHe Zhang2Tingjie  WangTingjie Wang3Yuxi  ChangYuxi Chang3Qingxin  XiaQingxin Xia2Bing  WeiBing Wei3
  • 1Center of Bio-Repository, The Affilated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, zhengzhou, China
  • 2Department of Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, zhengzhou, China
  • 3Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University& Henan Cancer Hospital, zhengzhou, China
  • 4The Kids Research Institute Australia, School of Medicine the University of Western Australia, Nedlands, Australia
  • 5School of Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, Australia
  • 6Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, zhengzhou, China

The final, formatted version of the article will be published soon.

Objective: Tertiary Lymphoid Structures (TLSs) are ectopic lymphoid aggregates that form within the tumor microenvironment (TME) and are increasingly recognized as potential prognostic biomarkers in various cancers. However, the spatial heterogeneity and prognostic value of TLSs in esophageal squamous cell carcinoma (ESCC) remain poorly defined. This study aimed to characterize the spatial distribution patterns of TLSs and tumor-infiltrating lymphocytes (TILs), and to establish a refined prognostic model for ESCC patients in both surgery-only and neoadjuvant therapy cohorts.The TLSs were quantified through microscopic evaluation and digital slide analysis and correlated with prognosis by Cox regression and Kaplan-Meier analyses. The heterogeneity and clinical prognostic value of TLSs were explored by analyzing their distribution, density, and maximum diameter in different regions of ESCC patients.Results: TLSs showed spatial distribution heterogeneity in the tumor area, adjacent area, and marginal area, with consistent differences observed across different paraffin blocks. The distribution of iTIL and sTIL also exhibited certain spatial heterogeneity. In the surgical cohort (n = 117), the median Overall Survival (OS) and Disease-Free Survival (DFS) were 33 months and 15 months, respectively. Univariate analyses showed that TLS presence in tumor (TG), TLS-rich regions (TR), TLS ratio in normal regions (NR), tumor-stroma ratio (TSR), and both iTIL and sTIL levels were significantly associated with OS ( p < 0.05). Multivariate analysis confirmed N stage, TG, TR, TLS abundance in adjacent regions (NA), and TLS density in tumor (NT), along with TSR, iTIL, and sTIL, as independent predictors of prognosis ( p < 0.05). High TLS presence in tumor regions (TG-high) was associated with significantly improved OS (log-rank p = 0.026).This study demonstrates that TLSs and TILs in ESCC are not only prognostically relevant but also spatially heterogeneous. The refined spatial immune profiling across multiple tumor regions improves prognostic stratification and may inform personalized treatment planning in ESCC.

Keywords: esophageal cancer, tertiary lymphoid structures, heterogeneity, prognosis their heterogeneity in Esophageal Squamous Univariate analysis revealed that T stage, N stage, TG, TR, nr

Received: 05 Apr 2025; Accepted: 21 Jul 2025.

Copyright: © 2025 Zhang, Bai, Hu, Wang, Ma, Zhang, Yuan, Tang, Zhang, Wang, Chang, Xia and Wei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Chengjuan Zhang, Center of Bio-Repository, The Affilated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, zhengzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.